Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients [Phase 1]
This entry reports a completed Phase 1b/2 trial evaluating ADG116 alone and in combination with anti-PD-1 or anti-CD137 antibodies in patien…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors [Phase 2]
A Phase 2 clinical trial is evaluating Cetuximab beta in combination with the PRaG regimen for EGFR-positive advanced refractory solid tumor…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors [NA]
This entry reports a recruiting clinical trial evaluating urolithin A in patients with previously untreated solid tumors receiving immune ch…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Impact of Physician Behavior on Cancer Distress
A Mayo Clinic-sponsored trial evaluating whether physician communication and behavior affect cancer-related distress in patients with hemato…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Clinical Trial of SIBP-A19 Injection in the Treatment of Advanced Malignant Solid Tumor Patients [Phase 1]
Phase 1 clinical trial evaluating SIBP-A19 Injection for advanced solid tumors, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors [Phase 1]
Phase 1 trial assessing safety and pharmacokinetics of the BGB-283 (lifirafenib) and PD-0325901 (mirdametinib) combination in adults with ad…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase I/IIa study of RC88-ADC in subjects with advanced malignant solid tumors.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Clinical Trial of SIBP-A18 Injection in the Treatment of Advanced Malignant Solid Tumor Patients [Phase 1]
Phase 1 clinical trial evaluating SIBP-A18 injection in adults with advanced malignant solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating GSK5764227 in combination with standard of care or other agents in participants with advanced solid tumors…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection [Phase 1]
Phase 1 study evaluating the safety, tolerability and pharmacokinetics of BAT8006 in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of WTX-330 in patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma has completed enrollment and posted re…
-
CLINICAL_TRIALS withdrawal · 2026-01-06Clinical Trial Update: Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating immune reconstitution monitoring and pneumococcal vaccination in patients treated with CAR-T cells has be…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events
This update describes Mayo Clinic's study using patient-derived induced pluripotent stem cells to model adverse events associated with cance…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Study of ZG005 in Patients With Advanced Solid Tumors [Phase 2]
A Phase 2 clinical trial evaluating ZG005 in patients with advanced solid tumors is currently recruiting in China.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS [Phase 1, Phase 2]
Clinical trial update for SHR-A1904 evaluating safety, tolerability, pharmacokinetics, and efficacy in subjects with advanced solid tumors. …
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors [Phase 1]
Phase I study to evaluate safety, tolerability, pharmacokinetics, and efficacy of YL211 in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study of Tuvusertib in combination with PLX038 in patients with advanced solid tumors was terminated.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Imaging of Solid Tumors Using FAP-2286 [Phase 1]
Phase 1 clinical trial exploring imaging of solid tumors in adults using the FAP-2286 tracer.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Impact of Immunotherapy on Vestibular Function, The Mayo Clinic Arizona Experience
A Mayo Clinic clinical trial update indicates ongoing enrollment by invitation to study the impact of immunotherapy on vestibular function i…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation [Phase 1]
Phase I first-in-human study evaluating GenSci128 in patients with solid tumors harboring a TP53 Y220C mutation; the trial is currently recr…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Special Drug Use-results Surveillance of Tafinlar/Mekinist
Clinical-trial update reporting ongoing surveillance of the dabrafenib/trametinib combination (Tafinlar/Mekinist) for BRAF V600E mutation-po…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309 [Phase 1]
A Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics of the investigational compound PMC-309 in patients with …
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating Denikitug (GS-1811) alone or with Zimberelimab in adults with advanced solid tumors is currently recruitin…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update shows AP601 being studied in locally unresectable advanced or metastatic solid tumors, with recruitment ongoing. The sp…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: T Cell Inflamed Gene Expression Profiling Score-guided Anti PD-1 Therapy (Tislelizumab Monotherapy) for Refractory Solid Cancer Patients Unexposed to Immunotherapy [Phase 2]
Phase 2 trial evaluating tislelizumab monotherapy guided by a T cell inflamed gene expression profiling score for refractory solid tumors in…